Citius OncologyCTOR

13F holders, Q2 2026 (June 30)
19holders +5
7new positions
2sold out
1famous investor
$0.65avg. 13F price*

At the end of Q2 2026, 19 institutions reported holding Citius Oncology Inc. (CTOR) in their 13F filings, up 5 from Q1 2026. 7 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($5.7M), Bank of America Corp. ($2.5M) and Vanguard Capital Management LLC ($355K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Citius Oncology Inc.
CUSIP
17331Y109
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q3 2024: 7Q3 2024Q4 2024: 11Q4 2024Q1 2025: 6Q1 2025Q2 2025: 7Q2 2025Q3 2025: 16Q3 2025Q4 2025: 18Q4 2025Q1 2026: 14Q1 2026Q2 2026: 19Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions7$96K
Exits2$29K

All 13F filers, Q1 2026 → Q2 2026: 456,810 shares bought and 559,357 shares sold, net −102,547 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 19 holders

Armistice Capital, LLC 0.16% Reduce -5.3% 8,705,589 $5.7M
Bank of America Corp. 0.00% No change 3,835,160 $2.5M
Vanguard Capital Management LLC 0.00% Add +2.1% 546,325 $355K
UBS Group AG 0.00% Add +808.3% 334,619 $218K
Geode Capital Management, LLC 0.00% Reduce -7.3% 245,407 $160K
Vanguard Fiduciary Trust Co. 0.00% No change 121,910 $79K
IFP Advisors, Inc 0.00% No change 107,424 $70K
Citadel Advisors 0.00% New 90,586 $59K
Northern Trust Corp. 0.00% No change 45,746 $30K
State Street Corp. 0.00% No change 42,900 $28K
Virtu Financial LLC 0.00% New 21,877 $14K
XTX Topco Ltd 0.00% New 20,638 $13K
Tower Research Capital LLC (TRC) 0.00% New 13,816 $9K
Arkadios Wealth Advisors 0.00% No change 11,666 $8K
Osaic Holdings, Inc. 0.00% Reduce -90.1% 1,000 $650
Wells Fargo & Company 0.00% New 500 $325
Barclays PLC 0.00% New 90 $59
Morgan Stanley 0.00% New 23 $15
Caitong International Asset Management Co., Ltd 0.00% No change 1 $1

"% of holder's portfolio" is CTOR's weight in each manager's 13F, not the share of Citius Oncology Inc. the manager owns.